Ashley Ghiaseddin, MD : Research

This is a phase I study to assess the safety and feasibility of IL-8 receptor modified patient-derived activated CD70 CAR T cell therapy in CD70+ adult glioblastoma.

Investigator

Ashley Ghiaseddin

Status

Accepting Candidates

Ages

18 Years - 80 Years

Sexes

All

The primary objective will be to demonstrate the manufacturing feasibility and safety, and to determine the maximum tolerated dose (MTD) of RNA-LP vaccines in (Stratum 1) adult patients with newly diagnosed GBM (MGMT unmethylated). Funding Source *…

Investigators

Marcia B Hodik, Ashley Ghiaseddin

Status

Accepting Candidates

Ages

21 Years - N/A

Sexes

All